Chronic obstructive pulmonary disease is a common, preventable and treatable disease. Exercise training programmes (ETPs) improve symptoms, health-related quality of life (HRQoL) and exercise capacity, but the optimal setting is unknown. In this review, we compared the effects of ETPs in different settings on HRQoL and exercise capacity. We searched (5 July 2016) the Cochrane Airways Group Specialised Register, ClinicalTrials.gov and World Health Organization trials portal. We selected studies, extracted data and assessed risk of bias with two independent reviewers. We calculated mean differences (MD) with 95% CI. We assessed the quality of evidence using Grades of Recommendation, Assessment, Development and Evaluation. Ten trials (934 participants) were included. Hospital (outpatient) and home-based ETPs (seven trials) were equally effective at improving HRQoL on the Chronic Respiratory Questionnaire (CRQ) (dyspnoea: MD −0.09, 95% CI: −0.28 to 0.10; fatigue: MD −0.00, 95% CI: −0.18 to 0.17; emotional: MD 0.10, 95% CI: −0.24 to 0.45; and mastery: MD −0.02, 95% CI: −0.28 to 0.25; moderate quality) and on the St George's Respiratory Questionnaire (SGRQ) (MD −0.82, 95% CI: −7.47 to 5.83, low quality). Hospital (outpatient) and community-based ETPs (three trials) were equally effective at improving HRQoL (CRQ dyspnoea: MD 0.29, 95% CI: −0.05 to 0.62, moderate quality; fatigue: MD −0.02, 95% CI: −1.09 to 1.05, low quality; emotional: MD 0.10, 95% CI: −0.40 to 0.59, moderate quality; and mastery: MD −0.08, 95% CI: −0.45 to 0.28, moderate quality). There was no difference in exercise capacity. There was low to moderate evidence that outpatient and home-based ETPs are equally effective.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable disease, characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. 1(p6) Airway obstruction leads to symptoms of persistent breathlessness, chronic productive cough, fatigue, an increased susceptibility to respiratory infections, 1 as well as systemic effects. 2 A diagnosis of COPD is based on symptoms and a postbronchodilator ratio of the forced expiratory volume in 1 s (FEV 1 ) to the forced vital capacity (FVC) of less than 0.70. people with chronic respiratory disease and to promote the long-term adherence to health-enhancing behaviours. 7(pe14) It aims to increase quality of life, reduce symptoms and improve physical and emotional participation. 1 National and international guidelines recommend incorporating PR in the management of COPD. 1, 8 A recent Cochrane review examining the effectiveness of PR for COPD compared to usual care concluded that PR leads to moderately large and clinically significant improvements in dyspnoea, fatigue, emotional function, health-related quality of life (HRQoL) and exercise capacity. 9 However, in their review, a more narrow definition of PR than the one above was used, consisting of exercise training regardless of the inclusion of additional PR components such as education, nutritional support and so on. We adhered to the scope of the definition used in the Cochrane review for consistency, but adopted more recent terminology; subsequently we used the term exercise training programmes (ETPs) instead of PR.
ETPs can be provided in different settings. [10] [11] [12] McCarthy et al. 9 conducted a subgroup analysis in their review for hospital-based and community-based programmes which suggested a difference in treatment effect between these settings. However, only studies that compared ETPs to usual care were included and studies comparing ETPs in different settings were excluded. To maximize the effectiveness of ETPs and target resources accordingly, it is essential to identify the optimal setting for delivering such programmes. The aim of this review was to compare the effects of ETPs in different settings on HRQoL and functional and maximal exercise capacity in persons with COPD.
METHODS

Search strategy and selection criteria
We identified trials (5 July 2016) from the Cochrane Airways Group Specialised Register (CAGR), which is populated through comprehensive systematic searching of multiple sources (Appendix S1 (Supplementary Information)). We searched ClinicalTrials.gov (www. ClinicalTrials.gov), the WHO trials portal (www.who. int/ictrp/en/) and the Epistemonikos database of reviews. We also searched PubMed from 1 January 2016 to 5 May 2016 to capture publications 'in press' and 'ahead of print' not yet indexed in Medline (Ovid). We did not apply any language restrictions.
We included randomized controlled trials (RCTs) including cluster RCTs, in whom >90% of participants had COPD defined as a clinical diagnosis of COPD and a best recorded FEV 1 /FVC ratio of <0.70 for individual participants. We included any ETPs of at least 4 weeks duration that included exercise therapy with/without any form of education and/or psychological support, and it had to be compared in at least two different settings. The primary outcome was disease-specific HRQoL, and secondary outcomes were maximal or functional exercise capacity, and cost-effectiveness measures, up to and including 3 months after the end of the intervention. Disease-specific HRQoL was measured using the Chronic Respiratory Questionnaire (CRQ), 13, 14 St George's Respiratory Questionnaire (SGRQ), 15, 16 or COPD assessment test (CAT). 17, 18 We defined maximal exercise capacity as the peak capacity measured by an incremental cycle ergometry test. Functional exercise capacity was defined according to the results of timed walk tests (6-min walk test/distance (6MWT/6MWD), incremental shuttle walk test/distance (ISWT/ISWD) and endurance shuttle walk test/distance (ESWT/ESWD)). 19 Cost-effectiveness measures included the use of healthcare resources associated with ETPs (direct/indirect, other non-medical costs) and the incremental cost-effectiveness ratios (ICERs) and quality-adjusted life years (QALYs) measures were assessed. We excluded RCTs that focussed on participants who were mechanically ventilated or who had an acute exacerbation within 4 weeks before commencement of the intervention and interventions that were not aerobically demanding (e.g. respiratory muscle training).
Study selection was conducted using the software Covidence (Veritas Health Innovation, Melbourne, Australia). 20 Two reviewers independently screened citations by title/abstract and by full-text (M.C., F.W., B.M., or M.M.). Any disagreement was resolved through discussion or by involving another reviewer (D.D.).
Two reviewers independently (M.C., F.W., or B.M.) assessed risk of bias (ROB) of included studies using the Cochrane ROB tool for intervention studies. 21 Consensus was reached through discussion or by getting a third opinion (D.D.). Three reviewers (M.C., F.W., B.M.) extracted data independently using a piloted form and consensus was reached by involving another reviewer (D.D.).
Data analysis
A priori specified primary (disease-specific HRQoL) and secondary outcomes (exercise capacity) measures were continuous variables; hence we abstracted the mean difference (MD) (and SD) from baseline to postintervention follow-up. We conducted meta-analyses in Revman. 22 For multi-armed trials, we only included the arms that received ETPs in any setting. If the MD from baseline was not reported, and baseline and follow-up data were provided, we calculated the MD, but the missing SD was substituted by the SD of the measurement at follow-up. Statistical heterogeneity was considered substantial if τ 2 >0 and either I 2 > 50% or the P-value < 0.10 for the chi-square test for heterogeneity. 21 We planned to assess publication bias (funnel plot), but the number of studies included was less than 10 for all analyses. We planned subgroup analysis for ETPs including education components versus exercise training alone, but insufficient studies were included.
The quality of evidence for the outcomes HRQoL and exercise capacity was assessed by two reviewers (B.M., M.M.) independently using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach. 23 The results are presented in Tables 1 and 2 and the GRADE profiles are provided in Appendix S5 (Supplementary Information). We have reported this review according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidance. 24 Since this was a review, no Institutional Review Board approval was required. GRADE Working Group grades of evidence High quality: we are very confident that the true effect lies close to that of the estimate of the effect; Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different; Low quality: our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect; Very low quality: we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. †
Blinding not performed in all studies included in analysis. This is an inherent problem due to the nature of the intervention in PR. ‡ Wide CI that includes appreciable benefit and harm. §
The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). 6MWD, 6 min walking distance; COPD, chronic obstructive pulmonary disease; CRQ, Chronic Respiratory Questionnaire; ETP, exercise training programme; GRADE, Grades of Recommendation, Assessment, Development and Evaluation; HRQoL, health-related quality of life; PR, pulmonary rehabilitation; RCT, randomized controlled trial; SGRQ, St George's Respiratory Questionnaire. GRADE Working Group grades of evidence High quality: we are very confident that the true effect lies close to that of the estimate of the effect; Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different; Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect; Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. †
The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). ‡
Blinding not performed in all studies included in analysis. This is an inherent problem due to the nature of the intervention in PR. § Wide CI that includes appreciable benefit and harm. ¶ Small number of participants and wide CI. COPD, chronic obstructive pulmonary disease; CRQ, Chronic Respiratory Questionnaire; ESWD, endurance shuttle walk distance; ETP, exercise training programme; FEV 1 , forced expiratory volume in 1 s; GRADE, Grades of Recommendation, Assessment, Development and Evaluation; HRQoL, health-related quality of life; PR, pulmonary rehabilitation; RCT, randomized controlled trial.
RESULTS
We identified 3991 records. After duplicate removal, 3972 records were screened by title/abstract and 57 by full-text. The most common reason for exclusion was the absence of a direct comparison between two different settings (n = 11) (Appendix S3, Supplementary Information). Six abstracts did not include sufficient information to assess their eligibility and the authors
have not yet responded to the request for more information ('awaiting classification'). Twenty-four records were included relating to 13 studies. One study was published in Spanish and was translated for this review. 25 The study selection process is presented in Figure 1 .
Five of the 13 included studies were trial registrations of which three did not have any published findings yet [26] [27] [28] ;
All 10 trials included a group that attended ETPs in an outpatient setting, of which 3 compared this to a community setting and 7 to a home-based programme. The duration ranged from 6 weeks to 3 months. The session frequency varied from daily to twice per week. Three studies included patients with severe/very severe COPD, but definitions varied from FEV 1 included patients with FEV 1 <70% of predicted value. Nygren-Bonnier et al. 44 did not specify inclusion criteria in their abstract, but participants had, on average, a FEV 1 <41.5% of predicted value. The baseline characteristics of participants are presented in Tables 3 and 4 . Figure 2 provides an overview of the ROB of the included studies and full details are provided in Appendix S4 (Supplementary Information). We judged six studies as having low ROB for random sequence generation (computer-generated/'lottery procedure'). The other four studies did not state how the sequence was generated. Six studies did not specify if allocation was concealed. Two studies allocated participants using sealed envelopes, in one study participants were invited to the hospital without knowing their allocation, 41 and one study emailed the allocation to research staff who then informed patients. 43, 45, 46 Exercise training is an intervention to which participants/ personnel cannot be blinded, resulting in high risk of performance bias. In six studies, the outcome assessment was conducted by someone who was blind to the group assignment. The other four studies did not report who conducted the assessment. Three studies had high attrition rates (<80% retention). 37, 39, 41 One study was judged as having high risk of reporting bias, since this record was a conference abstract. 44 We contacted the author, but did not receive a response.
Outpatient versus home-based ETPs
There was moderate-quality evidence that there is no difference between outpatient and home-based ETPs in improving HRQoL as measured by the CRQ domains of dyspnoea (MD −0.09, 95% CI: −0.28 to 0.10, four trials, 473 participants, I
2 0%, Figure S1 in Supplementary Information), fatigue (MD −0.00, 95% CI: −0.18 to 0.17, four trials, 473 participants, I
2 0%, Figure S2 2 65%, low-quality evidence, Figure S9 in Supplementary Information) and in incremental cycle ergometry (MD −9.0, 95% CI: −109.8 to 91.8, one trial, 233 participants, low-quality evidence) between outpatient and home-based ETPs. There was also no difference in performance in the ISWT (MD 13.0, 95% CI: −59.1 to 85.1, one trial, 50 participants, low-quality evidence) and in the ESWT (MD −73.0, 95% CI: −769.7 to 650.7, one trial, 50 participants, low-quality evidence).
Outpatient versus community-based ETPs
Outpatient and community-based ETPs were equally effective at improving HRQoL as measured by the CRQ domains of dyspnoea (MD 0.29, 95% CI: −0.05 to 0.62, two trials, 195 participants, I
2 0%, moderate-quality evidence, Figure S10 2 0%, moderate-quality evidence, Figure S13 in Supplementary Information). One study 37, 38 examined the difference in change in 6MWD and found a larger increase in distance from baseline in the outpatient group, but the sample was small (MD 66.9 m, 95% CI: −0.4 to 134.2, one trial, 31 participants, low-quality evidence). Another study [34] [35] [36] assessed the change in distance that participants could walk in 4 min before and after the programme, but found no difference in improvement between outpatient and community ETPs (MD 7.0 m, 95% CI: −37.1 to 51.1, one trial, 30 participants, low-quality evidence) and there was no difference in change in exercise capacity as measured by incremental cycle ergometry (MD 4.0, 95% CI: −11.0 to 19.0, one trial, 30 participants, low-quality evidence). [34] [35] [36] Waterhouse et al. 41 found no difference in the distance (MD 67.3 m, 95% CI: −40.8 to 175.4, one trial, 161 participants, low-quality evidence) and time walked (MD 1.1 min, 95% CI: −0.7 to 2.9, one trial, 160 participants, low-quality evidence) during the ESWT.
One study assessed the cost-effectiveness of outpatient versus community-based ETPs. 41 While the estimated mean costs and mean QALYs gained were higher for hospital-based ETPs relative to communitybased ETPs, neither result was significant at the 5% level of statistical significance. From a solely healthcare resource perspective, the estimated mean cost for the hospital-based programme was $5952.09 (SD: 5006.71) compared to $4807.55 (SD: 4373.05) for communitybased. This suggests that, with a strong assumption of equivalence in health outcomes across the settings, the community setting has the greater potential to generate cost savings, but the inclusion of only one study means that no definitive conclusions can be drawn.
DISCUSSION
The review found that, based on low-to moderatequality evidence, it is likely that the beneficial effects of ETPs as identified in the McCarthy et al. 9 review can be obtained across settings and different settings probably result in little to no difference in HRQoL and exercise capacity. In meeting current international clinical guidelines that recommend clearly the use of exercise training in the management of COPD, 1, 47 health services could tailor the setting of programmes to best suit One study (conference abstract) excluded at data extraction One study reported outcomes not reported in any other included studies and was excluded from meta-analyses Figure 1 Search results and study selection flowchart. CAGR, Cochrane Airways Group Specialised Register; PR, pulmonary rehabilitation; RCT, randomized controlled trial. Only the average for the whole group before randomization is reported. ‡ Baseline data of five participants that dropped out during the programme are not provided. A total of 50 participants enrolled initially. § Data from the groups that received outpatient ETPs followed by home ETPs and data for group that received outpatient ETPs followed by community ETPs are reported separately. Only the first phase (outpatient PR) for both groups was included in this review, since they received another intervention (different setting of PR) in the second phase of the study. C, community; ETP, exercise training programme; FEV 1 , forced expiratory volume after 1 s; H, home; NR, Not Reported; O, outpatient; PR, pulmonary rehabilitation. the local context, health services resources and importantly patients' needs, taking into consideration patient safety, particularly in unsupervised settings. Studies included in this review mostly defined and classified the severity of COPD according to FEV 1 , but this does not fully represent the heterogeneity of COPD, which in turn could impact on patients' response to such programmes. 48 Only 10 studies were identified that directly compared different settings for ETPs with some outcomes being only measured in one study. In assessing the quality of evidence (GRADE), the main reasons for downgrading were imprecision and ROB due to lack of blinding. While blinding of participants/personnel is inherently not possible in ETPs, there is a need for additional studies comparing their effectiveness in different settings to provide a more definite answer and improve the precision of the effect estimates.
Inpatient programmes were not examined in any of the included studies. Moreover, programmes that include PR components (e.g. nutrition, coping strategies) beyond exercise training should be examined. This should include assessing other important outcomes such as activities of daily living and mental health outcomes. The length, frequency and intensity of programmes, and their relation to the setting to achieve optimal outcomes, also warrant further investigation. The development of international indicators for the content, delivery and outcome measurement of PR would facilitate benchmarking of PR programmes. The near-absence of economic literature highlights the need for further primary research studies to be conducted to directly evaluate the relative costeffectiveness of ETPs and PR for the COPD patient population in different settings.
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